Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-021868

Options or other derivatives

  • Chief Operating Officer acquired 93,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-05 Grant or award : show line 1 in the form Restricted Stock Units +93,750 93,750 D
Loading xslF345X05/tm258333-7_4seq1.xml…